Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide

Michael Nowak, Mohammed S. Arredouani, Adrian Tun-Kyi et al. · 2010

Read Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide by Michael Nowak, Mohammed S. Arredouani, Adrian Tun-Kyi et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011311.txt.

Description

Nowak, Arredouani, Tun-Kyi and colleagues rescued immune cells in prostate tumors for PLOS ONE in 2010. A class of immune sentinels, NKT cells, should attack tumors but were poorly activated by prostate tumor cells. The team tested a pairing of an immune signal and a fat based activator to fix that fault.

The pairing corrected the defective activation in their experiments. Recruiting NKT cells back into the fight is a goal of cancer immunotherapy. A defined rescue recipe can be tested for wider use. It shows tumor immune faults may be reversible, not fixed, which widens treatment options.

Catalog record

CREATORMichael Nowak, Mohammed S. Arredouani, Adrian Tun-Kyi et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011311

Browse the full library · About the Tower of Babel